Assembly Biosciences Inc expected to post a loss of $2.02 a share - Earnings Preview
04/11/2024 23:26
* Assembly Biosciences Inc ASMB.OQ ASMB.O is expected
to show
a rise in quarterly revenue when it reports results on November
6 (estimated) for the period ending September 30 2024
* The South San Francisco California-based company is
expected to
report revenue of $8.645 million, according to the mean estimate
from 2 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Assembly Biosciences Inc
is
for a loss of $2.02 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Assembly
Biosciences Inc is $35.50, above its last closing price
of $16.89.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -2.23 -2.23 -1.98 Beat 11.2
Mar. 31 2024 -3.23 -3.23 -1.66 Beat 48.6
Dec. 31 2023 -2.88 -2.15 Beat 25.3
Sep. 30 2023 -2.76 -3.24 Missed -17.4
Jun. -3.46 -3.48 -3.84 Missed -10.3
30 2023
Mar. 31 2023 -4.31 -4.26 -4.44 Missed -4.2
Dec. 31 2022 -5.40 -5.52 Missed -2.2
Jan. 1 0001 -4.80 -5.64 -5.76 Missed -2.1
This summary was machine generated November 4 at 23:26 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)